Era Mandiri Cemerlang Tbk. vs Phapros Tbk. — how do they compare? Era Mandiri Cemerlang Tbk. trades at Rp87 (market cap 74.17B, 31.56M 24h volume), while Phapros Tbk. trades at Rp300 (market cap 221.76B, 7.89M 24h volume). The key difference: Phapros Tbk. is far larger — about 3× Era Mandiri Cemerlang Tbk.'s market cap, and Era Mandiri Cemerlang Tbk. is more actively traded (31.56M versus 7.89M). Which is the better fit depends on your goals.
| IKAN | PEHA | |
|---|---|---|
Market Cap | 74.17B | 221.76B |
Volume | 31.56M | 7.89M |
Lot | 315.65K | 78.91K |
Turnover | 2.84B | 2.48B |
Average Price | 90.04 | 314.91 |
Value | 2.84B | 2.48B |
Indicative Equilibrium Price | 87 | 300 |
Indicative Equilibrium Volume | 3.42K | 1.06K |
Trailing returns across standard periods
Latest headlines on both assets
PT Era Mandiri Cemerlang Tbk ("Company") was established with Deed Number 79, 14 November 2000 by Haji Muhammad Afdal Gazali, SH., a public notary in Jakarta.
Read more on IKAN →PT Phapros Tbk was established under the name of N.V. Pharmaceutical Processing Industries, in short N.V. Phapros, based on Notarial Deed No 54 of Tan A Sioe dated 21 June 1954, which later became PT Pharmaceutical Processing Industries, in short PT Phapros based on Notarial Deed No.43 of E. Pondaag, replacing R.M. Soerojo, dated 5 September 1995, which finally became PT Phapros based on Notarial Deed No. 48 of Prof. Dr. Liliana Tedjosaputro, S.H., M.H., MM., dated 12 April 2006. The Company’s immediate and ultimate parent entity is PT Rajawali Nusantara Indonesia, incorporatedand domiciled in Indonesia.
Read more on PEHA →